N-substituted (E)-4-arylidene isoquinoline-1,3-dione derivatives as potent
anticancer agents �?¢�?�?��?�?? Synthesis and molecular evaluations

Manik; an A.; Sivakumar A

Abstract

N-substituted (E)-4-arylidene isoquinoline-1,3-dione derivatives as potent anticancer agents �?¢�?�?��?�?? Synthesis and molecular evaluations

Author(s): Manikandan A. and Sivakumar A

This article describes a two-step synthesis of (E)-4-arylidene isoquinoline-1,3-dione derivatives and their anticancer effects. First, an intermediate N-aryl homophthalimide was synthesized using ZnO as the catalyst. Second, a new modified synthesis of (E)-4-arylidene isoquinoline-1,3-dione derivatives in the presence of oxalic acid in ethanol (EtOH). The obtained products were characterized by FT- IR, GC/MS, 1H NMR, and 13C NMR. Synthesized isoquinoline derivatives 5a-h possesses significant cytotoxic activity against MCF-7 cell lines. Molecular docking study results are disclosing the structure-activity similarity of the synthesized compounds with anticancer evaluations. IC50 ± SD values for the compounds 5g (3.57±0.54 μg/ml), 5h (3.89±0.82 μg/ml) and 5d (4.42±0.98μg/ml) were very close to the standard doxorubicin (3.36±0.38 μg/ml). The mean percentage of inhibition for doxorubicin was 70.39±7.18, for our compounds, it was 33.14±6.61 (5b) to 61.75±8.22 (5g). At the end of study, the necessity of in vivo animal model evaluations was understood and the same studies are progressing currently.

PDF

Select your language of interest to view the total content in your interested language